Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Linearx Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. KYLE THOMAS REGA is the busiest examiner for the company, responsible for 1 pending action. The prosecution involves a distinct examiner and a distinct art unit, reflecting a single active matter currently under review. This concentration indicates that the company's current patent activity is focused on a specific technical advancement within the biotech field.
With a distinct examiner and a distinct art unit, the company's immediate patent trajectory is determined by the decisions of KYLE THOMAS REGA. There is no diversification across different examiners or art units, which means the company is focusing its current prosecution resources on a single point of contact at the patent office. This approach requires a strategy tailored to the specific art unit and examiner handling the case, as there are no other active matters to provide alternative paths to allowance.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGA, KYLE THOMAS | 1 | 62.7% | +41.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734772 | COMPOSITIONS AND METHODS FOR RNA SYNTHESIS | REGA, KYLE THOMAS | 9d |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18734772 | COMPOSITIONS AND METHODS FOR RNA SYNTHESIS | REGA, KYLE THOMAS | 1636 | §112 | Final Rejection | 9d | Pending | Jun 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial